Concepedia

Candy Wilson

CW

23

Publications

991

Citations

16

H-Index

2005

Active since

Affiliations

Takeda (United States)(Current)

Deerfield (United States)

Uniformed Services University of the Health Sciences

Joint Base San Antonio

Wilford Hall Ambulatory Surgical Center

Candy Wilson is an author at Takeda (United States) specializing in medicine, women's health, and public health.

ORCID

Top concepts

Publications per year

2005–2023

23

Publications

23

Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy

Richard E. Pratley, Mark Kipnes, P. Fleck et al. · Diabetes Obesity and Metabolism · 2008 · 160 citations

Cardiovascular safety of the dipetidyl peptidase‐4 inhibitor alogliptin in type 2 diabetes mellitus

William B. White, Richard E. Pratley, P. Fleck et al. · Diabetes Obesity and Metabolism · 2013 · 117 citations

Efficacy and Tolerability of the DPP-4 Inhibitor Alogliptin Combined with Pioglitazone, in Metformin-Treated Patients with Type 2 Diabetes

Ralph A. DeFronzo, Charles Burant, P. Fleck et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 99 citations · Full text

Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study

Björn Eliasson, Diane L. Möller-Goede, Katarina Eeg‐Olofsson et al. · Diabetologia · 2012 · 88 citations · Full text

, , +9

Alogliptin versus glipizide monotherapy in elderly type 2 diabetes mellitus patients with mild hyperglycaemia: a prospective, double‐blind, randomized, 1‐year study

Julio Rosenstock, Candy Wilson, P. Fleck · Diabetes Obesity and Metabolism · 2013 · 82 citations

Rows per page

1–5 of 23